Brain Wealthy
    What's Hot

    The Brain Observatory: New Museum to Participate in Museum Month

    February 1, 2023

    Therapist Hong Kong News – Counseling and therapy practice treats post-corona depression anxiety and stress Hong Kong

    February 1, 2023

    Klamath County mental health treatment beds to double in planned expansion

    February 1, 2023
    Facebook Twitter Instagram
    Facebook Twitter Instagram
    Brain Wealthy
    • Home
    • Anxiety

      Therapist Hong Kong News – Counseling and therapy practice treats post-corona depression anxiety and stress Hong Kong

      February 1, 2023

      Pokemon Scarlet & Violet players fail ‘anxiety-inducing’ shiny encounters due to jump glitch

      February 1, 2023

      Can Mindfulness Soothe Anxiety? The trial suggests yes. – Harvard Gazette

      February 1, 2023

      Best CBD for dog anxiety

      February 1, 2023

      Studies find that prolonged exposure to dirty air may increase the risk of depression and anxiety

      February 1, 2023
    • Emotion

      Stephen ‘tWitch’ Boss’ mother shares emotional reaction to seeing his Gap campaign: ‘I almost called you’

      February 1, 2023

      ‘It’s like, really emotional’: Quakertown students Q&A with Super Bowl-bound Eagles player | Southeast Pennsylvania

      February 1, 2023

      Delight in Cafes: Tweets Reveal Where People Express Different Emotions in a City

      February 1, 2023

      Want to be happier?Millions of Tweets Show Your Location May Affect Your Emotions

      February 1, 2023

      Shane Beamer Recaps the Rollercoaster of Emotions with South Carolina Recruiter Nichols Haber

      February 1, 2023
    • Neurology

      Repairing cerebrospinal fluid leaks may improve symptoms

      February 1, 2023

      Fear of Public Places Associated with Poor Quality of Life in Adults with Epilepsy

      February 1, 2023

      Novartis discontinues Huntington’s disease program after Phase 2b trial

      February 1, 2023

      Postmenopausal stroke risk dates back to women’s reproductive age

      February 1, 2023

      5 Clinical Trial Readouts in Neurology to Look for in 2023

      February 1, 2023
    • Sleep

      Centrepoint will try to sleep out this February.

      February 1, 2023

      Experience America’s Favorite Mattress Tempur-Pedic With The Best Mattress Sleep Specialists – St. George News

      February 1, 2023

      Simple remedies for a good night’s sleep

      February 1, 2023

      Joe Pera launches ‘Drift Off’ podcast to help us fall asleep (again)

      February 1, 2023

      Brandon Guyer opined on the importance of sleep in favor of the use of pitch timers in MLB.

      February 1, 2023
    • Brain Research

      The Brain Observatory: New Museum to Participate in Museum Month

      February 1, 2023

      who wants to live forever

      February 1, 2023

      UK company makes surprise forays

      February 1, 2023

      Actionable Strategy Report on Brain-Inspired Computing Market

      February 1, 2023

      Disparities associated with differences in brain structure among US children

      February 1, 2023
    • Brain Wealth
      1. Mental Health
      2. View All

      Klamath County mental health treatment beds to double in planned expansion

      February 1, 2023

      WIU Introduces Mental Health Awareness Organization to Campus

      February 1, 2023

      Windsor Spitfires Partners with CMHA Windsor-Essex to Host Mental Health Awareness Game

      February 1, 2023

      Mental Health Support – Leeds Parish

      February 1, 2023

      Klamath County mental health treatment beds to double in planned expansion

      February 1, 2023

      WIU Introduces Mental Health Awareness Organization to Campus

      February 1, 2023

      Windsor Spitfires Partners with CMHA Windsor-Essex to Host Mental Health Awareness Game

      February 1, 2023

      Mental Health Support – Leeds Parish

      February 1, 2023
    Brain Wealthy
    Home»Brain Research»Alzheimer’s disease breakthrough: new therapeutic target found
    Brain Research

    Alzheimer’s disease breakthrough: new therapeutic target found

    brainwealthy_vws1exBy brainwealthy_vws1exJanuary 8, 2023No Comments5 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Diagram of brain connection network

    Alzheimer’s disease is a progressive brain disorder that affects memory, thinking, and behavior. It is the most common cause of dementia in the elderly and is characterized by loss of brain cells and shrinkage of brain tissue. According to the World Health Organization, Alzheimer’s disease affects about 50 million people worldwide, and this number is expected to triple by 2050.

    Researchers at the German Center for Neurodegenerative Diseases (DZNE) have found that the protein medin co-aggregates with amyloid-β within the blood vessels of the brain.[{” attribute=””>Alzheimer’s patients. Their findings were recently published in the prestigious journal Nature.

    “Medin has been known for over 20 years, but its influence on diseases was previously underestimated. We were able to show that pathological changes in the blood vessels of Alzheimer’s patients are significantly enhanced by medin,” says Dr. Jonas Neher from the Tübingen site of the DZNE, who led the study.

    The Hertie Institute for Clinical Brain Research in Tübingen, the University of Tübingen, and various international institutions and partners were also involved in this long-term project.

    Medin belongs to the group of amyloids. Of these proteins, amyloid-β is best known because it clumps together in the brains of Alzheimer’s patients. These aggregates then deposit both as so-called plaques directly in the brain tissue, but also in its blood vessels, thereby damaging the nerve cells and the blood vessels, respectively. But while many studies have focused on amyloid-β, medin has not been a focus of interest. “There was little evidence of pathology, that is, of a clinically striking finding associated with medin – and that is often the prerequisite for a more in-depth study of an amyloid,” Jonas Neher explains.

    However, medin is actually found in the blood vessels of almost everybody over 50 years of age, making it the most common amyloid known. With his team, Jonas Neher originally found that medin even develops in aging mice, and reported this discovery two years ago in the scientific journal PNAS. The older the mice get, the more medin accumulates in the blood vessels of their brains, was the finding at the time. What’s more, when the brain becomes active and triggers an increase in blood supply, vessels with medin deposits expand more slowly than those without medin. This ability of blood vessels to expand, however, is important to optimally supply the brain with oxygen and nutrients.

    For their latest results, the researchers built on this foundation and looked specifically at Alzheimer’s disease. First, they were able to show in Alzheimer’s mouse models that medin accumulates even more strongly in the brain’s blood vessels if amyloid-β deposits are also present. Importantly, these findings were confirmed when brain tissue from organ donors with Alzheimer’s dementia was analyzed. However, when mice were genetically modified to prevent medin formation, significantly fewer amyloid-β deposits developed, and as a result, less damage to blood vessels occurred.

    “There are only a handful of research groups worldwide working on medin at all,” says Jonas Neher. Most recently, a study from the U.S. reported that medin levels may increase in Alzheimer’s patients. However, it remained unclear whether this increase is merely a consequence of the disease or whether it is one of the causes.

    “We have now been able to show through many experiments that medin actually promotes vascular pathology in Alzheimer’s models,” Neher said. So medin deposits are indeed a cause of blood vessel damage. “And this indicates that medin is one of the causes of the disease,” Neher said.

    In their studies, the researchers stained tissue sections from both mice and Alzheimer’s patients in such a way that specific proteins become visible. This allowed them to show that medin and amyloid-β are deposited together in blood vessels of the brain – co-localization is the technical term for this. In the next step, they were able to prove that these two amyloids also co-aggregate – that is, form mixed deposits.

    “Amazingly, medin interacts directly with amyloid-β and promotes its aggregation – this was completely unknown,” Jonas Neher summarizes the results.

    It is precisely from this insight that the researchers draw hope for the development of a new treatment. “Medin could be a therapeutic target to prevent vascular damage and cognitive decline resulting from amyloid accumulation in the blood vessels of the brain,” they conclude. It is undisputed among experts that in addition to amyloid-β aggregates in brain tissue, the development of Alzheimer’s disease is also promoted by vascular alterations – that is, reduced function or damage to blood vessels. Therefore, treatments that target not only plaques but also affected blood vessels could help patients.

    Next, it will now be necessary to determine if medin aggregates can be removed therapeutically and whether this intervention actually has an effect on cognitive performance. The scientists first want to test this in mouse models, because these reflect the pathological changes in Alzheimer’s patients very well.

    Reference: “Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease” by Jessica Wagner, Karoline Degenhardt, Marleen Veit, Nikolaos Louros, Katerina Konstantoulea, Angelos Skodras, Katleen Wild, Ping Liu, Ulrike Obermüller, Vikas Bansal, Anupriya Dalmia, Lisa M. Häsler, Marius Lambert, Matthias De Vleeschouwer, Hannah A. Davies, Jillian Madine, Deborah Kronenberg-Versteeg, Regina Feederle, Domenico Del Turco, K. Peter R. Nilsson, Tammaryn Lashley, Thomas Deller, Marla Gearing, Lary C. Walker, Peter Heutink, Frederic Rousseau, Joost Schymkowitz, Mathias Jucker and Jonas J. Neher, 16 November 2022, Nature.
    DOI: 10.1038/s41586-022-05440-3





    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticlePrince Harry reveals he had agoraphobia in book: Symptoms to know
    Next Article Health workers applaud FG for signing mental health bill
    brainwealthy_vws1ex
    • Website

    Related Posts

    The Brain Observatory: New Museum to Participate in Museum Month

    February 1, 2023

    who wants to live forever

    February 1, 2023

    UK company makes surprise forays

    February 1, 2023
    Add A Comment

    Leave A Reply Cancel Reply

    Top Posts

    Subscribe to Updates

    Get the latest sports news from SportsSite about soccer, football and tennis.

    This website provides information about Brain and other things. Keep Supporting Us With the Latest News and we Will Provide the Best Of Our To Makes You Updated All Around The World News. Keep Sporting US.

    Facebook Twitter Instagram Pinterest YouTube
    Top Insights

    Top UK Stocks to Watch: Capita Shares Rise as it Unveils

    January 15, 2021
    8.5

    Digital Euro Might Suck Away 8% of Banks’ Deposits

    January 12, 2021

    Oil Gains on OPEC Outlook That U.S. Growth Will Slow

    January 11, 2021
    Get Informed

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    © 2023 brainwealthy. Designed by brainwealthy.
    • Home
    • Contact us
    • DMCA
    • Privacy Policy

    Type above and press Enter to search. Press Esc to cancel.